Description of Novo Integrated Sciences Inc's Business Segments

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Annual Report on Novo Integrated Sciences Inc Divisions, Sales by Country


Healthcare Services	65.12 %	of total Revenue
Product Sales	38.6 %	of total Revenue
Corporate Segment	0.61 %	of total Revenue

Twelve months ended 2024
NVOS s Annual Revenue by Geography and Business Segments	Sales (in millions $)	% (of total Sales)
Healthcare Services	8.30	65.12 %
Product Sales	4.92	38.6 %
Corporate Segment	0.08	0.61 %
Total	12.74	100 %

Twelve months ended 2024
NVOS s Annual Income by Country and Business Segments	Income (in millions $)	% (Profit Margin)
Healthcare Services	3.10	37.41 %
Product Sales	2.56	52.06 %
Corporate Segment	0.08	100 %
Total	-16.13	-

Twelve months ended 2024
Annual Revenue and Income Growth by Country and Business Segments	% Y/Y Sales Growth	% Y/Y Income Growth
Healthcare Services	0.86 %	3.52 %
Product Sales	13.45 %	31.66 %
Corporate Segment	706.7 %	706.78 %

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.